Figure 3From: Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies Placebo-adjusted endpoint mean pain by pregabalin dosage. The upper panel (A) shows placebo-adjusted endpoint mean pain for pooled age groups. The lower panel (B) shows placebo-adjusted endpoint mean pain by age and dosage group. Bars represent the 95% confidence interval. *p < 0.0001 versus placebo. **p ≤ 0.0009 versus placebo.Back to article page